BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Samson R, Dharne M. COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis. 3 Biotech 2022;12:6. [PMID: 34900512 DOI: 10.1007/s13205-021-03080-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kyuno D, Kubo T, Tsujiwaki M, Sugita S, Hosaka M, Ito H, Harada K, Takasawa A, Kubota Y, Takasawa K, Ono Y, Magara K, Narimatsu E, Hasegawa T, Osanai M. COVID-19-associated disseminated mucormycosis: An autopsy case report. World J Clin Cases 2022; 10(28): 10358-10365 [DOI: 10.12998/wjcc.v10.i28.10358] [Reference Citation Analysis]
2 Krishna V, Bansal N, Morjaria J, Kaul S. COVID-19-Associated Pulmonary Mucormycosis. JoF 2022;8:711. [DOI: 10.3390/jof8070711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 García-carnero LC, Mora-montes HM. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis. JoF 2022;8:445. [DOI: 10.3390/jof8050445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Girdhar D, Manocha E. A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics. BioMed 2022;2:181-98. [DOI: 10.3390/biomed2020017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Azhar A, Khan WH, Khan PA, Al-hosaini K, Owais M, Ahmad A. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach. Journal of Infection and Public Health 2022. [DOI: 10.1016/j.jiph.2022.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]